Sec Form 4 Filing - McCamy William C. @ Thorne Healthtech, Inc. - 2023-10-16

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person McCamy William C. 2. Issuer Name and Ticker or Trading Symbol Thorne Healthtech, Inc. [ THRN] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) President (Last) (First) (Middle) C/O THORNE HEALTHTECH, INC., 152 W. 57TH STREET 3. Date of Earliest Transaction (MM/DD/YY) 10/16/2023 (Street) NEW YORK, NY10019 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 10/16/2023 D 589,804 ( 1 ) D 0 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Employee Stock Option (Right to buy) $ 1.1573 10/16/2023 D 156,640 ( 2 ) 02/13/2024 Common Stock 156,640 $ 0 0 D Employee Stock Option (Right to buy) $ 1.1573 10/16/2023 D 17,355 ( 2 ) 02/13/2024 Common Stock 17,355 $ 0 0 D Employee Stock Option (Right to buy) $ 1.1573 10/16/2023 D 31,150 ( 2 ) 02/13/2024 Common Stock 31,150 $ 0 0 D Employee Stock Option (Right to buy) $ 1.1573 10/16/2023 D 39,605 ( 2 ) 02/13/2024 Common Stock 39,605 $ 0 0 D Employee Stock Option (Right to buy) $ 1.3483 10/16/2023 D 89,000 ( 2 ) 02/12/2025 Common Stock 89,000 $ 0 0 D Employee Stock Option (Right to buy) $ 4.4944 10/16/2023 D 178,000 ( 2 ) 02/12/2025 Common Stock 178,000 $ 0 0 D Employee Stock Option (Right to buy) $ 6.7416 10/16/2023 D 186,900 ( 2 ) 02/12/2025 Common Stock 186,900 $ 0 0 D Employee Stock Option (Right to buy) $ 5.1236 10/16/2023 D 639,910 ( 2 ) 10/10/2028 Common Stock 639,910 $ 0 0 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other McCamy William C. C/O THORNE HEALTHTECH, INC. 152 W. 57TH STREET NEW YORK, NY10019 President Signatures /s/ Kim Pearson, under power of attorney 10/18/2023 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Certain of these shares are represented by previously reported restricted stock units ("RSUs"). At the effective time of the merger (the "Effective Time") contemplated by the Agreement and Plan of Merger between the Issuer, Healthspan Buyer, LLC and Healthspan Merger Sub, Inc., dated as of August 27, 2023 (the "Merger Agreement"), (i) each issued and outstanding RSU was cancelled and converted into the right to receive an amount equal to $10.20 in cash (the "Per Share Price"), subject to the terms set forth in the Merger Agreement, and (ii) each issued and outstanding share of the Issuer's Common Stock was cancelled and converted into the right to receive an amount in cash equal to the Per Share Price. ( 2 )At the Effective Time, the option was cancelled pursuant to the Merger Agreement in exchange for a cash payment equal to (x) the difference between the Per Share Price and the per share exercise price of the option, multiplied by (y) the number of disposed option shares.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.